Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Diagnos Laboratorium Utama Tbk. (DGNS) vs Tempo Scan Pacific Tbk. (TSPC)

Diagnos Laboratorium Utama Tbk.Trading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Diagnos Laboratorium Utama Tbk. dan Tempo Scan Pacific Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.520 (kapitalisasi pasar 11,18 T, volume 24 jam 613 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 36× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Diagnos Laboratorium Utama Tbk. lebih aktif diperdagangkan (963,6 rb vs 613 rb). Mana yang lebih baik tergantung tujuan investasimu.

DGNSTSPC
Kapitalisasi Pasar
310,75 M11,18 T
Volume
963,6 rb613 rb
Lot
9,64 rb6,13 rb
Perputaran
217,67 jt1,54 M
Harga Rata-rata
225,892.511,52
Nilai Transaksi
217,67 jt1,54 M
Harga Ekuilibrium Indikatif
2262.520
Volume Ekuilibrium Indikatif
1 rb17

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

DGNS
Lihat detail
TSPC
Lihat detail

Tentang Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Selengkapnya di halaman DGNS

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC